Growth in Net Sales and Orders
Net sales increased by 2% in constant currencies, with a strong 21% order growth in constant exchange rates compared to last year, driven by performance in Europe and APAC.
Successful Product Launches
Elekta Evo, the latest AI-powered adaptive CT-Linac, and Elekta ONE Planning software suite were well received, contributing to order and sales growth, particularly in Europe.
Record High Cash Flow
Cash flow after continuous investments increased to SEK730 million, a record high for the third quarter, supported by higher EBITDA, lower investments, and reduction of working capital.
Cost Reduction Achievements
Cost reduction initiatives led to SEK264 million in annual run rate savings for the first nine months, ahead of plan and target.
High Customer Satisfaction
Elekta received the Best-in-Class award based on feedback from thousands of clinical users, highlighting the success of its digital solutions and software investments.